Their in vivo and in vitro models revealed that serum EXOs from PCOS mice lacked miR-128-3p, resulting in increased expression of its direct target, CSF1, and the subsequent activation of p38/JNK/NRF2 signaling. This evidence concerns the gene MAPK1 and polycystic ovary syndrome.